The ASAM Buprenorphine Course for Office-Based Treatment of Opioid Use Disorders

BUP Course_Information Banner


The Drug Abuse Treatment Act of 2000 (DATA 2000) specifies training is necessary for physicians to obtain a waiver to engage in office‐based treatment of opioid use disorders using drugs approved by the FDA on Schedules III, IV, and V. This course addresses those requirements using a curriculum approved by CSAT/SAMHSA and ASAM, one of the national organizations named in the DATA 2000 legislation as eligible to prepare and administer these courses.

ASAM offers this 8 hour course in a blended format combining online and live learning to meet the needs of today’s busy physicians. The first half of the course is administered online through 4 hours of independent self-paced learning followed by a competency exam which must be successfully completed as part of the process to obtain a waiver for prescribing buprenorphine. The second half of the course is delivered by recognized national experts in a 4 hour interactive and engaging face to face classroom setting.

The ASAM Buprenorphine Course will ensure that participants are exposed to the highest quality, evidence-based practices when using buprenorphine to treat opioid use disorders.The case-based learning formats to show learners how to apply this new knowledge.

Education Purpose

The combined independent online study and face-to-face live education will provide the required 8 hours needed to obtain the waiver to prescribe buprenorphine in office-based treatment of opioid use disorders.

Learning Objectives

To achieve this goal the following specific objectives have been identified:

  • Apply for a waiver to prescribe buprenorphine to their patients with opioid use disorders.
  • Identify and assess patients who are appropriate for treatment with buprenorphine.
  • Have a specific knowledge concerning the use of buprenorphine to manage opioid addicted patients.
  • Discuss the psychiatric and medical co-morbidities associated with opioid addiction.

Who Should Attend

The ASAM Buprenorphine Course is designed for:

  • Physicians who wish to obtain a waiver to prescribe buprenorphine in office based treatment of opioid use disorders.
  • Clinicians and health care team members working with physicians who prescribe buprenorphine in office based treatment of opioid use disorders.

Questions? Contact ASAM’s Education Department

American Society of Addiction Medicine
4601 North Park Avenue
Upper Arcade, Suite 101
Chevy Chase, MD 20815-4520
Education Department
Phone: 301-656-3920 | Fax: 301-656-3815 | Email: | Web: